Fig. 7From: Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironmentsRemodeling of ECM mechanism by exosomal miRNA. The primary tumor cells release exosomes which were taken up by the normal fibroblasts (NFs) receptors, wherein the exosomal miR-124 derived ovarian cancer, miR-27B-3P, miR-214-3P derived myeloma, and miR-27a derived gastric cancer target the proteins (SPHK1, FBXW7, CSRP2), while miR-10b derived colorectal cancer inhibits PIK3CA leading to activation of fibroblast to cancer-associated fibroblasts (CAFs) by increasing the expression of α-SMA, and FAP and regulates CAFs migration and invasion. miR-155 derived melanoma inhibits SOCS1and promote activation of FGF2, VEGFA, MMP9 in CAFs. miR-21 derived HCC decrease PTEN leading to activation of PDK1/AKT signaling pathway and increasing expression of VEGF, MMP2, MMP9, βFGF and TGF-β in CAFs, promoting angiogenesis. Exosomal miRNA-derived breast cancer such as miR-9 activates NFs to CAFs by increasing MMP1, EFEMP1, COL1A1, and miR-105 inducing metabolic reprogramming of CAFs by activating MYC signalBack to article page